Introduced
by
To authorize liability exemptions for a public agency that purchases, possesses, or distributes an opioid antagonist, and for staff members that administer an opioid antagonist to an individual having an overdose.
Referred to the Committee on Health Policy and Human Services
Reported without amendment
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Passed in the Senate 38 to 0 (details)
Referred to the Committee on Health Policy
Reported without amendment
Refer to the Committee on Judiciary.
Referred to the Committee on Judiciary
Reported without amendment
Without amendment and with the recommendation that the bill pass.
Passed in the House 107 to 0 (details)
To authorize liability exemptions for a public agency that purchases, possesses, or distributes an opioid antagonist, and for staff members that administer an opioid antagonist to an individual having an overdose.
